Fermentation specialist Biomedican plans to spin off a subsidiary that will be focused on astaxanthin production via a bioengineered yeast, the company said recently.
Israeli's Algatechnologies is considering ways to extend its
business beyond astaxanthin. It is investigating opportunities to
derive other nutritional ingredients and biofuel from microalgae.
Japanese firm guarantees products are free of ethoxyquin, a
chemical preservative not permitted in human foodstuffs, following
last week's voluntary recall.